Price$4.49+0.08 (+1.93%)
2026-07-162026-10-16
News · 26 weeks67+88%
2026-04-192026-10-11
Mix3390d
- Insider18(55%)
- SEC Filings6(18%)
- Other4(12%)
- Earnings2(6%)
- Leadership2(6%)
- Analyst1(3%)
Latest news
25 items- SECSEC Form 8-K filed by Clover Health Investments Corp.8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRClover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027WILMINGTON, Del., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that the Centers for Medicare & Medicaid Services ("CMS") has awarded its PPO Medicare Advantage ("MA") plans a rating of 5 Stars and its HMO MA plan a rating of 4.5 Stars for 2027, which will affect payment year 2028. Through the first half of 2026, Clover Health grew Medicare Advantage membership ~48% year-over-year to more than 157,000 members, with ~98% enrolled in its wide-network PPO plans. At 5 Stars, Clover’s PPO plans will be able to enroll beneficiaries year round. Each year, CMS assigns Star ratings to Medicare Advantag
- INSIDERSEC Form 4 filed by Clover Health Investments Corp.4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- PRClover Health to Report Third Quarter 2026 Financial Results on November 4, 2026WILMINGTON, Del., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced that it will release its financial results after the market closes on Wednesday, November 4, 2026. The Company’s management will host a webcast presentation at 5:00 p.m. Eastern Time on the same day to discuss the company’s business and financial performance for the quarter. Third Quarter 2026 Conference Webcast Details: What: Clover Health’s Third Quarter 2026 Earnings Conference CallWhen: Wednesday, November 4, 2026, at 5:00 p.m. Eastern TimeWebcast: To access the webcast, you may register at https://clover-health-3q-2026-earni
- INSIDERSEC Form 4 filed by Clover Health Investments Corp.4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERDirector Miller Brian James was granted 12,481 shares (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERDirector Torricelli Robert G was granted 12,481 shares, increasing direct ownership by 7% to 186,897 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Executive Officer Toy Andrew sold $1,335,797 worth of shares (318,806 units at $4.19), decreasing direct ownership by 3% to 9,140,510 units (SEC Form 4) to cover taxes4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERNew insider Torricelli Robert G claimed ownership of 174,416 shares (SEC Form 3)3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERSEC Form 3 filed by new insider Miller Brian James3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- PRClover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member ValueWILMINGTON, Del., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced its 2027 Medicare Advantage (MA) plan offerings, with a continued focus on PPO choice, affordable access to preventive care and meaningful member value. Clover’s Medicare Advantage model is powered by Clover Assistant (CA), which is designed to give physicians across Clover’s broad provider network access to relevant patient information to identify care needs and support better-informed clinical decisions. Clover Hea
- SECAmendment: Clover Health Investments Corp. filed SEC Form 8-K: Financial Statements and Exhibits, Leadership Update8-K/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRUPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of DirectorsWILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and business. Senator Torricelli will serve on the Board’s Audit Committee, and Dr. Miller will serve on its Clinical Committee. The appointments fill the Board’s two previously disclosed vacancies and br
- SECClover Health Investments Corp. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- PRClover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of DirectorsWILMINGTON, Del., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company") today announced the appointments of former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to the Company’s Board of Directors, effective immediately. The appointments bring together two accomplished leaders whose complementary experience spans public service, Medicare Advantage, clinical practice, healthcare policy, and business. Senator Torricelli will serve on the Board’s Audit Committee, and Dr. Miller will serve on its Clinical Committee. The appointments fill the Board’s two previously disclosed vacancies and br
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $8,760 worth of shares (1,921 units at $4.56) as part of a pre-agreed trading plan, decreasing direct ownership by 0.07% to 2,803,446 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERVP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $14,709 worth of shares (3,170 units at $4.64), decreasing direct ownership by 1% to 275,897 units (SEC Form 4) (withholding obligation)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Counterpart Health Wai Conrad sold $1,416,000 worth of shares (300,000 units at $4.72) as part of a pre-agreed trading plan (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERChief Legal Officer Soares Karen sold $32,724 worth of shares (6,846 units at $4.78), decreasing direct ownership by 0.42% to 1,607,371 units (SEC Form 4) (for withholding tax)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERCEO, Medicare Advantage Reynoso Jamie L. sold $44,325 worth of shares (9,273 units at $4.78), decreasing direct ownership by 0.33% to 2,805,367 units (SEC Form 4) to satisfy withholding tax4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- INSIDERVP OF FINANCE AND CONTROLLER Oldakowski Joseph Frank sold $103,200 worth of shares (20,000 units at $5.16), decreasing direct ownership by 7% to 279,067 units (SEC Form 4)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
- ANALYSTDeutsche Bank initiated coverage on Clover Health with a new price targetDeutsche Bank initiated coverage of Clover Health with a rating of Buy and set a new price target of $6.00
- PRClover Health to Participate in Upcoming Investor ConferencesWILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), today announced its participation in the following investor conferences: Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Jefferies Healthcare Services and Technology Conference on Tuesday, September 15, 2026, at 1:40 p.m. Eastern Time. A live webcast and replay of the presentation will be accessible from Clover Health's investor relations website at https://investors.cloverhealth.com/.Interim Chief Financial Officer, Clay Thornton, will participate in the Deutsche Bank 2026 Healthcare Summit on Wednesday, September 16, 20
- SECClover Health Investments Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)
- INSIDERInterim CFO Thornton Joseph Clay sold $78,032 worth of shares (17,775 units at $4.39), decreasing direct ownership by 1% to 1,249,526 units (SEC Form 4) (tax liability)4 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)
CLOV FAQ
6 questionsWhat does Clover Health Investments Corp. do?
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.Where does CLOV stock trade?
Clover Health Investments Corp. (CLOV) is listed on NASDAQ.What sector and industry is CLOV in?
Clover Health Investments Corp. operates in the Health Care sector, Medical Specialities industry.What are analysts saying about CLOV?
Clover Health Investments Corp. has had 8 recent analyst actions on file. The most recent action was from Deutsche Bank: Buy with a $600.00 price target on 2026-09-10. Recent price targets range from $250.00 to $600.00.What companies are similar to CLOV?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare CLOV side-by-side with any of them on Quantisnow.How can I track CLOV on Quantisnow?
Quantisnow aggregates Clover Health Investments Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLOV to receive live email and push alerts on every new disclosure.